The Enterprise Value as of September 2024 (TTM) for Aileron Therapeutics, Inc. (ALRN) is 39.80M

According to Aileron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 39.80M. This represents a change of 3.46% compared to the average of 38.47M of the last 4 quarters.

Aileron Therapeutics, Inc. (ALRN) Historical Enterprise Value (quarterly & annually)

How has ALRN Enterprise Value performed in the past?

The mean historical Enterprise Value of Aileron Therapeutics, Inc. over the last ten years is 46.65M. The current 39.80M Enterprise Value has changed 8.43% with respect to the historical average. Over the past ten years (40 quarters), ALRN's Enterprise Value was at its highest in in the September 2017 quarter at 173.09M. The Enterprise Value was at its lowest in in the September 2023 quarter at -5166426.16.

Aileron Therapeutics, Inc. (ALRN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aileron Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aileron Therapeutics, Inc. (ALRN) Average Enterprise Value

How has ALRN Enterprise Value performed in the past?

The current Enterprise Value of Aileron Therapeutics, Inc. (ALRN) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Aileron Therapeutics, Inc. (ALRN) Enterprise Value vs. Peers

How is ALRN’s Enterprise Value compared to its peers?

Aileron Therapeutics, Inc.’s Enterprise Value is greater than Applied Molecular Transport Inc. (-5743713.00), greater than Catalyst Biosciences, Inc. (19.42M), greater than Bio-Path Holdings, Inc. (-1322244.00), less than Benitec Biopharma Inc. (70.22M), greater than Artelo Biosciences, Inc. (1.33M), greater than Histogen Inc. (-3643892.00), less than Curis, Inc. (66.63M), greater than Timber Pharmaceuticals, Inc. (-798315.00), greater than Evelo Biosciences, Inc. (16.69M), greater than Aptinyx Inc. (-13266343.00), greater than Magenta Therapeutics, Inc. (-114170976.00), greater than ABVC BioPharma, Inc. (10.52M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (64.97M), less than Assembly Biosciences, Inc. (95.68M), less than Instil Bio, Inc. (486.73M), less than Nuvation Bio Inc. (1.02B), greater than First Wave BioPharma, Inc. (9.55M), greater than Salarius Pharmaceuticals, Inc. (-995790.00), greater than SAB Biotherapeutics, Inc. (13.85M), greater than Vaccinex, Inc. (9.65M), greater than GeoVax Labs, Inc. (21.42M),

Build a custom stock screener for Aileron Therapeutics, Inc. (ALRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aileron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aileron Therapeutics, Inc. (ALRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aileron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.